News Related to Rivaroxaban

Related coverage linked through entity extraction aliases.

Bayer Leverages AI, Precision Medicine, and Pipeline Growth to Drive 2030 Strategy

Jul 03, 2026

Bayer outlined its 2030 growth strategy at Pharma Media Day 2026, driven by AI partnerships, precision medicine, and a strengthened pipeline. The company aims for mid-single-digit growth from 2027 and 30% margins by 2030.

Pharma Faces $200-300 Billion Patent Cliff Through 2032 as Blockbusters Lose Exclusivity

Feb 16, 2026

The global biopharmaceutical industry entered 2026 facing one of the largest waves of patent expirations in its history, with $200-300 billion in yearly sales at risk through 2032 as major drugs lose exclusivity.